Showing results (461-470 of 600) with videos related to
Sort By:
Pageof 60
Diabetes Technology & Therapeutics|October 28, 2014
A decision support tool for appropriate glucose-lowering therapy in patients with type 2 diabetesF Javier Ampudia-Blasco, Pierre Yves Benhamou, Guillaume Charpentier, et al.Diabetologia|July 30, 2025
The heterogeneity of type 1 diabetes: implications for pathogenesis, prevention, and treatment-2024 Diabetes, Diabetes Care, and Diabetologia Expert ForumCarmella Evans-Molina, Yuval Dor, Åke Lernmark, et al.Diabetes Care|July 30, 2025
The Heterogeneity of Type 1 Diabetes: Implications for Pathogenesis, Prevention, and Treatment-2024 Diabetes, Diabetes Care, and Diabetologia Expert ForumCarmella Evans-Molina, Yuval Dor, Åke Lernmark, et al.Diabetes, Obesity & Metabolism|August 28, 2024
Health-related quality of life of people with type 1 diabetes: An IMI2 SOPHIA post hoc analysis of FUTURE and ADJUNCT-ONENele Steenackers, Thomas Sparsø, Sara Charleer, et al.Eclinicalmedicine|March 18, 2024
Effectiveness of a blended mobile-based lifestyle intervention in women with glucose intolerance after a recent history of gestational diabetes (MELINDA): a 1-year, prospective, multicentre, randomised controlled trialCaro Minschart, Nele Myngheer, Toon Maes, et al.Diabetes Care|March 31, 2017
Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (onset 1)David Russell-Jones, Bruce W Bode, Christophe De Block, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 26, 2014
1,25-Dihydroxyvitamin D3 promotes tolerogenic dendritic cells with functional migratory properties in NOD miceGabriela B Ferreira, Conny A Gysemans, Jocelyne Demengeot, et al.Diabetologia|January 18, 2024
Cost-utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in BelgiumMargaretha M Visser, Astrid Van Muylder, Sara Charleer, et al.Diabetes Care|October 17, 2020
Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE StudySara Charleer, Christophe De Block, Frank Nobels, et al.Human Vaccines & Immunotherapeutics|July 3, 2020
Vaccination coverage of recommended vaccines and determinants of vaccination in at-risk groupsLise Boey, Eline Bosmans, Liane Braz Ferreira, et al.Pageof 60